Genethera Inc (GTHR) financial statements (2022 and earlier)

Company profile

Business Address 3051 W 105TH AVENUE
WESTMINSTER, CO 80031
State of Incorp. NV
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

9/30/2021
TTM
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments  55168  
Cash and cash equivalents  55168  
Receivables      22
Prepaid expense 1     
Total current assets: 155168 22
Noncurrent Assets
Property, plant and equipment 11162126  
Other noncurrent assets    12 111
Other undisclosed noncurrent assets   12  13
Total noncurrent assets: 11163338 124
TOTAL ASSETS: 122138206 146
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 6,8806,1205,8734,8194,3864,142
Accounts payable 8128776684725926
Accrued liabilities 6,7996,0925,0974,1363,6613,217
Debt 2626265151,380672
Due to related parties 732742771 1,029268
Other liabilities     326 
Other undisclosed current liabilities 55551,301  1,588
Total current liabilities: 7,6926,9427,9705,3347,1216,670
Noncurrent Liabilities
Other undisclosed liabilities    2,059  
Total liabilities: 7,6926,9427,9707,3937,1216,670
Stockholders' equity
Stockholders' equity attributable to parent, including: (7,681)(6,921)(7,932)(7,187)(7,121)(6,578)
Preferred stock    01515
Common stock 243636409437
Additional paid in capital 23,47623,44922,56919,27418,58318,405
Accumulated deficit (31,260)(30,485)(30,616)(26,571)(25,814)(25,035)
Other undisclosed stockholders' equity attributable to parent 80808070  
Other undisclosed stockholders' equity (0)    54
Total stockholders' equity: (7,681)(6,921)(7,932)(7,187)(7,121)(6,524)
TOTAL LIABILITIES AND EQUITY: 122138206 146

Income statement (P&L) ($ in thousands)

9/30/2021
TTM
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Operating expenses (741)(739)(3,927) (680)(901)
Operating loss: (741)(739)(3,927) (680)(901)
Nonoperating income
(Other Nonoperating income)
     39 
Interest and debt expense (34)(29)(118) 138(185)
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes  250(0)   
Loss from continuing operations before equity method investments, income taxes: (774)(518)(4,045) (504)(1,085)
Other undisclosed loss from continuing operations before income taxes     (275) 
Loss before gain (loss) on sale of properties: (774)(518)(4,045) (779)(1,085)
Other undisclosed net loss    (758)  
Net loss available to common stockholders, diluted: (774)(518)(4,045)(758)(779)(1,085)

Comprehensive Income ($ in thousands)

9/30/2021
TTM
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss: (774)(518)(4,045)(758)(779)(1,085)
Comprehensive loss, net of tax, attributable to parent: (774)(518)(4,045)(758)(779)(1,085)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: